Examining the relationship between HbA1c and diabetes risk models in a European population indicates a lower...

Area of Science:

• Endocrinology
• Cardiovascular Risk Assessment
• Public Health

Background:

• Glycated hemoglobin (HbA1c) is a key indicator of long-term glycemic control.
• Validated risk-assessment tools are used to predict type 2 diabetes risk.
• Understanding the relationship between HbA1c and these risk scores is crucial for early intervention.

Purpose of the Study:

• To investigate if changes in HbA1c values align with risk scores and categories from four established risk-assessment tools.
• To determine the association between HbA1c levels and predicted type 2 diabetes risk.
• To compare high-risk category HbA1c values with existing clinical recommendations.

Main Methods:

• Retrospective analysis of 651 UK individuals without prior cardiovascular disease or diabetes diagnoses.
• Assessment of correlations between HbA1c values and risk scores from QDiabetes, Leicester Risk Assessment, Finnish Diabetes Risk Score, and Cambridge Risk Score.
• Examination of HbA1c trends within different risk prediction categories.

Main Results:

• Significant positive correlations were found between HbA1c and predicted risk scores for all four tools (p < 0.01).
• HbA1c values demonstrated an increasing trend across risk prediction categories.
• Median HbA1c in 'high-risk' categories was ≥39 mmol/mol (5.7%), regardless of gender or tool used.

Conclusions:

• An association exists between increasing HbA1c levels and predicted type 2 diabetes risk.
• The 'high-risk' thresholds identified align more closely with lower American recommendations than UK guidelines.
• Risk-assessment tools appear to reflect glycemic changes indicated by HbA1c levels.